Javed Butler, Kendall Hammonds, Khawaja M Talha, Ayman Alhamdow, Monica M Bennett, J Vee Anne Bomar, Jason A Ettlinger, Monica Martinez Traba, Elisa L Priest, Niklas Schmedt, Cecilia Zeballos, Courtney N Shaver, Aasim Afzal, Robert J Widmer, Robert L Gottlieb, Michael J Mack, Milton Packer
{"title":"急性心肌梗死后的心力衰竭和复发性冠状动脉事件","authors":"Javed Butler, Kendall Hammonds, Khawaja M Talha, Ayman Alhamdow, Monica M Bennett, J Vee Anne Bomar, Jason A Ettlinger, Monica Martinez Traba, Elisa L Priest, Niklas Schmedt, Cecilia Zeballos, Courtney N Shaver, Aasim Afzal, Robert J Widmer, Robert L Gottlieb, Michael J Mack, Milton Packer","doi":"10.1093/eurheartj/ehae885","DOIUrl":null,"url":null,"abstract":"Background and Aims Recurrent myocardial infarction (MI) and incident heart failure (HF) are major post-MI complications. Herein, contemporary post-MI risks for recurrent MI and HF are described. Methods A total of 6804 patients with a primary discharge diagnosis of MI at 28 Baylor Scott & White Health hospitals (January 2015 to December 2021) were studied. Patient characteristics, treatment, and outcomes, including incident HF, recurrent MI, all-cause death, and all-cause and cardiovascular rehospitalizations, were assessed. Landmark approach anchored at 3 months post-discharge was used to assess 1-year outcomes. Results Median age was 69 years, 59.7% were male, and 76.7% had non-ST-elevation MI. Comorbidities included hypertension (89%), dyslipidaemia (87%), Type 2 diabetes (48%), and chronic kidney disease (34%); 17% had a history of MI and 23% of HF; 63% underwent percutaneous/surgical revascularization. In landmark-anchored 1-year outcomes (N = 6210), 413 (6.7%) patients died, 1730 (27.9%) had all-cause and 735 (11.8%) cardiovascular hospitalizations, 234 (3.8%) had recurrent MI. Of patients without history of HF, 1160 (23.8%) developed incident HF [42.2%, 26.7%, and 31.1% with ejection fraction (EF) < 40%, 41–49%, and >50%, respectively) within 3 months of discharge. Patients who developed HF had higher risk of death and hospitalizations (all P < .001), irrespective of EF. Of 2179 patients with EF > 50% without prevalent HF or HF during index hospitalization, 257 (11.8%) developed HF and 77 (3.5%) recurrent MI within 1 year. Conclusions In a contemporary post-MI cohort, the risk for incident HF was greater than recurrent MI, even among those with normal EF and no HF at discharge.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"25 1","pages":""},"PeriodicalIF":45.3000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incident heart failure and recurrent coronary events following acute myocardial infarction\",\"authors\":\"Javed Butler, Kendall Hammonds, Khawaja M Talha, Ayman Alhamdow, Monica M Bennett, J Vee Anne Bomar, Jason A Ettlinger, Monica Martinez Traba, Elisa L Priest, Niklas Schmedt, Cecilia Zeballos, Courtney N Shaver, Aasim Afzal, Robert J Widmer, Robert L Gottlieb, Michael J Mack, Milton Packer\",\"doi\":\"10.1093/eurheartj/ehae885\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and Aims Recurrent myocardial infarction (MI) and incident heart failure (HF) are major post-MI complications. Herein, contemporary post-MI risks for recurrent MI and HF are described. Methods A total of 6804 patients with a primary discharge diagnosis of MI at 28 Baylor Scott & White Health hospitals (January 2015 to December 2021) were studied. Patient characteristics, treatment, and outcomes, including incident HF, recurrent MI, all-cause death, and all-cause and cardiovascular rehospitalizations, were assessed. Landmark approach anchored at 3 months post-discharge was used to assess 1-year outcomes. Results Median age was 69 years, 59.7% were male, and 76.7% had non-ST-elevation MI. Comorbidities included hypertension (89%), dyslipidaemia (87%), Type 2 diabetes (48%), and chronic kidney disease (34%); 17% had a history of MI and 23% of HF; 63% underwent percutaneous/surgical revascularization. In landmark-anchored 1-year outcomes (N = 6210), 413 (6.7%) patients died, 1730 (27.9%) had all-cause and 735 (11.8%) cardiovascular hospitalizations, 234 (3.8%) had recurrent MI. Of patients without history of HF, 1160 (23.8%) developed incident HF [42.2%, 26.7%, and 31.1% with ejection fraction (EF) < 40%, 41–49%, and >50%, respectively) within 3 months of discharge. Patients who developed HF had higher risk of death and hospitalizations (all P < .001), irrespective of EF. Of 2179 patients with EF > 50% without prevalent HF or HF during index hospitalization, 257 (11.8%) developed HF and 77 (3.5%) recurrent MI within 1 year. Conclusions In a contemporary post-MI cohort, the risk for incident HF was greater than recurrent MI, even among those with normal EF and no HF at discharge.\",\"PeriodicalId\":11976,\"journal\":{\"name\":\"European Heart Journal\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":45.3000,\"publicationDate\":\"2025-01-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/eurheartj/ehae885\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehae885","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的复发性心肌梗死(MI)和心衰(HF)是心肌梗死后的主要并发症。本文描述了当代心肌梗死后复发性心肌梗死和心衰的风险。方法6804例初步出院诊断为心肌梗死的患者在美国贝勒斯科特医院(Baylor Scott &;研究对象为白人健康医院(2015年1月至2021年12月)。评估患者特征、治疗和结果,包括心衰事件、复发性心肌梗死、全因死亡、全因和心血管再住院。出院后3个月采用里程碑式方法评估1年预后。结果中位年龄为69岁,男性59.7%,非st段抬高型心肌梗死76.7%,合并症包括高血压(89%)、血脂异常(87%)、2型糖尿病(48%)、慢性肾病(34%);17%有心肌梗死史,23%有心衰史;63%的患者接受了经皮/手术血管重建术。在具有里程碑意义的1年结局(N = 6210)中,413例(6.7%)患者死亡,1730例(27.9%)有全因住院,735例(11.8%)有心血管住院,234例(3.8%)有复发性心肌梗死。在没有HF病史的患者中,1160例(23.8%)发生了突发HF[射血分数(EF)和lt;分别为40%、41% - 49%和50%)。发生心衰的患者有较高的死亡和住院风险(P <;.001),与EF无关。2179例EF患者;50%的患者在指数住院期间没有流行HF或HF, 257例(11.8%)发生HF, 77例(3.5%)在1年内复发心肌梗死。结论:在当代心肌梗死后队列中,即使在EF正常且出院时无心衰的患者中,发生心衰的风险大于心肌梗死复发。
Incident heart failure and recurrent coronary events following acute myocardial infarction
Background and Aims Recurrent myocardial infarction (MI) and incident heart failure (HF) are major post-MI complications. Herein, contemporary post-MI risks for recurrent MI and HF are described. Methods A total of 6804 patients with a primary discharge diagnosis of MI at 28 Baylor Scott & White Health hospitals (January 2015 to December 2021) were studied. Patient characteristics, treatment, and outcomes, including incident HF, recurrent MI, all-cause death, and all-cause and cardiovascular rehospitalizations, were assessed. Landmark approach anchored at 3 months post-discharge was used to assess 1-year outcomes. Results Median age was 69 years, 59.7% were male, and 76.7% had non-ST-elevation MI. Comorbidities included hypertension (89%), dyslipidaemia (87%), Type 2 diabetes (48%), and chronic kidney disease (34%); 17% had a history of MI and 23% of HF; 63% underwent percutaneous/surgical revascularization. In landmark-anchored 1-year outcomes (N = 6210), 413 (6.7%) patients died, 1730 (27.9%) had all-cause and 735 (11.8%) cardiovascular hospitalizations, 234 (3.8%) had recurrent MI. Of patients without history of HF, 1160 (23.8%) developed incident HF [42.2%, 26.7%, and 31.1% with ejection fraction (EF) < 40%, 41–49%, and >50%, respectively) within 3 months of discharge. Patients who developed HF had higher risk of death and hospitalizations (all P < .001), irrespective of EF. Of 2179 patients with EF > 50% without prevalent HF or HF during index hospitalization, 257 (11.8%) developed HF and 77 (3.5%) recurrent MI within 1 year. Conclusions In a contemporary post-MI cohort, the risk for incident HF was greater than recurrent MI, even among those with normal EF and no HF at discharge.
期刊介绍:
The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters.
In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.